Search Orphan Drug Designations and Approvals
-
Generic Name: | Pralsetinib |
---|---|
Date Designated: | 02/22/2022 |
Orphan Designation: | Treatment of metastatic RET fusion-positive solid tumors |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Genentech, Inc 1 DNA Way South San Francisco, California 94080 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-